Jordan Traverso

The primary discussion topic for the meeting materials concerns the batch tagging of mature cannabis plants, following recent statutory changes that allow for tagging larger quantities of mature plants under a single tag, moving away from the current requirement for individual tagging. The committee is requested to provide input on potential structures for batch tagging (e.g., by number, strain, or row), appropriate limitations, desirability for cultivators, regulatory pros and cons, and considerations related to the existing Metrc contract costs and future hemp integration by 2028. The Department is also seeking data points related to tagging timeframes and harvest time averages.

The meeting included discussions on various topics such as the cost of cannabis licensing, potential toxicity of metric tags, reassessing licensing fees, the need for a testing lab representative on the committee, potency inflation, conflicts between state cannabis regulations and local control, issues with dual products, problems with metric submissions, and the risks of cannabis use during pregnancy.

The Cannabis Advisory Committee held a meeting to discuss several key issues. The committee approved the minutes from the previous meeting. A motion was passed to remove the cap on the number of products and eliminate limitations on product types, with a recommendation for further discussion with the DCC after these changes are implemented. The committee also recommended the implementation of SB 1064. Future discussion items include batch tagging of cannabis plants, youth programs, and tax allocations toward youth programs.

The committee discussed various topics, including the timeline for formal actions, environmental reviews, and potential cost savings by deferring to local jurisdictions. A significant portion of the discussion was dedicated to licensing fees, with concerns raised about the sustainability of increasing fees, the burden on struggling businesses, and the disproportionate impact on cultivators. Suggestions were made to re-evaluate the fee structure, consider rebates based on revenue, index fees to market rates, and incentivize sustainable practices. The committee also explored the possibility of using tax revenue to offset licensing costs and questioned the expenses associated with the metric system.

The meeting focused on opening a discussion to define the subcommittee's scope and identify and prioritize topics for the subcommittee to focus on in 2023. The topics of interest included presentations by subject matter experts and discussions around high THC products, access to hospitals, Ryan's law, medicinal products versus adult use products, and the impact of limited access to broad spectrum cannabinoids.